Oncologic Emergencies: An Overview for the Intensivist

The Old, the New, and the Deadly

Title Slide

    Title

    Oncologic Emergencies: An Overview for the Intensivist

    Subtitle

    The Old, the New, and the Deadly

    Author

    Krishna Thandra, MD, et al.

    Source

    J Intensive Care Med. 2020 Jan; 35(1): 3-13

    Introduction

      Global Impact of Cancer

      Cancer is a leading cause of death globally, but advancements in care have led to a decline in mortality rates.

      ICU Admissions

      Patients with cancer make up a significant portion of ICU admissions (14-22%).

      Intensivist Awareness

      Intensivists must be aware of the unique emergencies associated with cancer and its treatments.

      Presentation of Emergencies

      Oncologic emergencies can be an initial presentation of the disease or a complication of its treatment.

      Febrile Neutropenia

        Definition

        A single oral temperature of 38.3°C (101°F) in a patient with an absolute neutrophil count (ANC) of less than 1500/µL.

        Risk Factors

        Rapid decline of ANC, recent chemotherapy, current immunosuppression, and cardiovascular comorbidities.

        Etiology

        Often due to a variety of organisms, though a specific causative organism is only identified in a minority of patients. Common organisms are listed in table 2.

        Management

        Empiric antibiotic therapy is the mainstay of treatment, selected based on clinical status and other factors.

        Hyperleukocytosis / Leukostasis

          Definition

          An extreme form of leukocytosis with a white blood cell (WBC) count >100,000/µL.

          Pathophysiology

          High quantity of WBCs can clump together, causing impaired microvascular flow, tissue hypoxia, and hemorrhage.

          Highest Risk

          Patients with hematologic malignancies especially acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL).

          Management

          Initial management includes aggressive hydration with calcium and potassium-free fluids; definitive treatment involves chemotherapy to decrease tumor load; leukapheresis for symptomatic patients or very high WBC counts; refer to flowchart 2 for detailed strategies.

          Tumor Lysis Syndrome (TLS)

            Definition

            A group of metabolic abnormalities that occur due to the rapid breakdown of tumor cells and the release of their contents into the bloodstream.

            Metabolic Abnormalities

            Hyperkalemia, hyperphosphatemia, and hyperuricemia, which can lead to hypocalcemia and acute kidney injury (AKI).

            Diagnosis

            Based on clinical and laboratory criteria from the Cairo and Bishop classification system (fig 3).

            Management

            Management strategies for TLS, including addressing metabolic imbalances and supportive care (note: content incomplete in source).